MK

Mahendrakumar Kashiram Patel

Director DIN 02693925
DIN 02693925 First appointment Jul 2009
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahendrakumar Kashiram Patel

Data last updated:

Mahendrakumar Kashiram Patel was a Director at Bhaktisuri Shares And Services Private Limited (from 2009) and Director at Khodal Pharmaceuticals Private Limited (from 2012).

DIN 02693925
First Appointment 03 Jul 2009
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jul 20092009Amalgamated
Director30 Mar 20122011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bhaktisuri Shares And Services Private Limited
Khodal Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mahendrakumar Kashiram Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahendrakumar Kashiram Patel

Mahendrakumar Kashiram Patel was first appointed on 03 Jul 2009 as Director at Bhaktisuri Shares And Services Private Limited. The most recent appointment on record is 30 Mar 2012 at Khodal Pharmaceuticals Private Limited.

Mahendrakumar Kashiram Patel held 2 earlier board appointments: Bhaktisuri Shares And Services Private Limited (Director, from 03 Jul 2009); Khodal Pharmaceuticals Private Limited (Director, from 30 Mar 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available